Cargando…

Discovery of a novel target for cancer: PRR14

Detalles Bibliográficos
Autores principales:	Xiao, Shaowen, Yang, Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	News and Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5261014/ https://www.ncbi.nlm.nih.gov/pubmed/27906191 http://dx.doi.org/10.1038/cddis.2016.401

Ejemplares similares

Discovery of a novel target for renal cell carcinoma: transglutaminase 2
por: Kang, J H, et al.
Publicado: (2016)

A novel role of PRR14 in the regulation of skeletal myogenesis
por: Yang, M, et al.
Publicado: (2015)

The PRR14 heterochromatin tether encodes modular domains that mediate and regulate nuclear lamina targeting
por: Dunlevy, Kelly L., et al.
Publicado: (2020)

A new dimension in drug discovery: reversing epithelial–mesenchymal transition (EMT)
por: Yun-Ju Huang, Ruby, et al.
Publicado: (2016)

Increased PRR14 and VCAM-1 level in serum of patients with Parkinson's disease
por: Zheng, Huimin, et al.
Publicado: (2022)

αTAT1: a potential therapeutic target in cancer?
por: Chien, J-Y, et al.
Publicado: (2016)

PRR11 in Malignancies: Biological Activities and Targeted Therapies
por: Han, Wei, et al.
Publicado: (2022)

Cancer: A Tale of Aberrant PRR Response
por: Nagi, Raunaq Singh, et al.
Publicado: (2014)

From discovery of tyrosine phosphorylation to targeted cancer therapies: The 2018 Tang Prize in Biopharmaceutical Science
por: Yu, Jau-Song
Publicado: (2019)

Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses
por: Vasou, Andri, et al.
Publicado: (2017)

Oncogene PRR14 promotes breast cancer through activation of PI3K signal pathway and inhibition of CHEK2 pathway
por: Ren, Xiaolei, et al.
Publicado: (2020)

PRR14 acts a novel oncogene activating the PI3K signal pathway in human cutaneous squamous cell carcinoma
por: Zhang, Lili, et al.
Publicado: (2023)

First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer
por: Besbes, S, et al.
Publicado: (2015)

A novel proinflammatory role for granzyme A
por: van Eck, Jacqueline A, et al.
Publicado: (2017)

The discovery of tubulin
por: Wells, William A.
Publicado: (2005)

Control of HIV replication by a novel constitutively active ‘super-PRR’
por: Gupta, S, et al.
Publicado: (2012)

TSPO as a target for treatments of diseases, including neuropathological disorders
por: Veenman, L, et al.
Publicado: (2015)

Denial and Distraction: How the Populist Radical Right Responds to COVID-19 Comment on "A Scoping Review of PRR Parties’ Influence on Welfare Policy and its Implication for Population Health in Europe"
por: Falkenbach, Michelle, et al.
Publicado: (2020)

Pseudo-Response Regulator (PRR) Homologues of the Moss Physcomitrella patens: Insights into the Evolution of the PRR Family in Land Plants
por: Satbhai, Santosh B., et al.
Publicado: (2011)

The discovery of synaptic vesicles
por: Wells, William A.
Publicado: (2005)

Discovery of a Novel Bat Gammaherpesvirus
por: Host, Kurtis M., et al.
Publicado: (2016)

PRR14 overexpression promotes cell growth, epithelial to mesenchymal transition and metastasis of colon cancer via the AKT pathway
por: Li, Fangfang, et al.
Publicado: (2019)

PRR14 organizes H3K9me3-modified heterochromatin at the nuclear lamina
por: Kiseleva, Anna A., et al.
Publicado: (2023)

Deciphering the true antiproliferative target of an MK2 activation inhibitor in glioblastoma
por: Brennan, P E
Publicado: (2016)

Novel β-carbolines inhibit Wnt/β-catenin signaling
por: Kong, L, et al.
Publicado: (2015)

Cdc14 in good repair
por: Short, Ben
Publicado: (2010)

Ins and outs of Cdc14
por: Leslie, Mitch
Publicado: (2010)

The lure of the lipids: how defensins exploit membrane phospholipids to induce cytolysis in target cells
por: Baxter, Amy A, et al.
Publicado: (2017)

PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer
por: Song, Zongchang, et al.
Publicado: (2015)

Novel function of cytoplasmic p53 at the interface between mitochondria and the endoplasmic reticulum
por: Kroemer, G, et al.
Publicado: (2015)

PRR11 and SKA2 promote the proliferation, migration and invasion of esophageal carcinoma cells
por: Chen, Jie, et al.
Publicado: (2020)

A macrophage mystery leads to dendritic discovery
por: Powell, Kendall
Publicado: (2005)

A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer
por: Nucera, Carmelo
Publicado: (2019)

The discovery of natalizumab, a potent therapeutic for multiple sclerosis
por: Steinman, Lawrence
Publicado: (2012)

Drug discovery in China: A snapshot of recent progress
por: Hu, Hongxi, et al.
Publicado: (2022)

Gluconeogenesis combats cancer: opening new doors in cancer biology
por: Khan, M W, et al.
Publicado: (2015)

PRR15 Is a Novel Diagnostic and Prognostic Biomarker in Papillary Thyroid Cancer and Modulates the Tumor Microenvironment
por: Wang, Lingli, et al.
Publicado: (2022)

Histamine: a potential cytoprotective agent to improve cancer therapy?
por: Martinel Lamas, D J, et al.
Publicado: (2015)

Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
por: Xia, Hongping, et al.
Publicado: (2017)

Fumarate drives EMT in renal cancer
por: Sciacovelli, Marco, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_45df75ns3co6csnbvcp3n1062i